Am. J. Respir. Crit. Care Med., Vol 154, No. 1, Jul 1996, 43-49.
Muscarinic inhibitory autoreceptors in different generations of human airways
RE ten Berge, J Zaagsma and AF Roffel
Department of Medicinal Chemistry and Molecular Pharmacology, University of Groningen, The Netherlands.
The present study was undertaken to investigate the functional presence of
inhibitory muscarinic M2 autoreceptors on postganglionic cholinergic nerve
endings in different generations of human airways. To this end, the effects
of the M2-selective muscarinic receptor antagonists AQ-RA 741 and gallamine
were studied on electrical field stimulation-induced twitch contractions of
preparations from trachea and from bronchial airways of varying diameter.
Furthermore, electrically evoked release of endogenous acetylcholine from
human bronchial preparations, and the effect of the muscarinic receptor
antagonist atropine thereon, was measured by high-performance liquid
chromatography. On average, twitch contractions were significantly but only
slightly (11 to 15%) potentiated by M2-selective concentrations of AQ-RA
741 and gallamine, despite approximately half of the preparations showing
no potentiation at all. A subdivision into airway generations showed that
M2 autoreceptor function was not readily detectable in bronchioles and
subsegmental bronchi. By contrast, both with AQ-RA 741 and gallamine a
clear potentiation (26 to 36%) of the twitch contractions was observed in
approximately half of the terminal bronchi and in all central airway
preparations. Moreover, the evoked release of endogenous acetylcholine in
terminal and subsegmental bronchi was significantly facilitated by
atropine, to 162 to 189% of controls. These results provide strong and
partly direct evidence for the existence of inhibitory muscarinic M2
receptors on postganglionic cholinergic nerve endings in human central
airways and subsegmental and terminal bronchi, but not in bronchioli. It
remains to be established, however, why these M2 receptors exhibit a rather
variable functionality in regulating cholinergic nerve-mediated contraction
in different airway generations.
This article has been cited by other articles:

|
 |

|
 |
 
Y. Bai, M. Zhang, and M. J. Sanderson
Contractility and Ca2+ Signaling of Smooth Muscle Cells in Different Generations of Mouse Airways
Am. J. Respir. Cell Mol. Biol.,
January 1, 2007;
36(1):
122 - 130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Sarria, E. Naline, Y. Zhang, J. Cortijo, M. Molimard, J. Moreau, P. Therond, C. Advenier, and E. J. Morcillo
Muscarinic M2 receptors in acetylcholine-isoproterenol functional antagonism in human isolated bronchus
Am J Physiol Lung Cell Mol Physiol,
November 1, 2002;
283(5):
L1125 - L1132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Douglas, H. A. Baghdoyan, and R. Lydic
M2 Muscarinic Autoreceptors Modulate Acetylcholine Release in Prefrontal Cortex of C57BL/6J Mouse
J. Pharmacol. Exp. Ther.,
December 1, 2001;
299(3):
960 - 966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Patel, M. A. Giembycz, J. E. Keeling, P. J. Barnes, and M. G. Belvisi
Inhibition of Cholinergic Neurotransmission in Guinea Pig Trachea by NS1619, a Putative Activator of Large-Conductance, Calcium-Activated Potassium Channels
J. Pharmacol. Exp. Ther.,
August 1, 1998;
286(2):
952 - 958.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R W Costello, D B Jacoby, and A D Fryer
Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity
Thorax,
July 1, 1998;
53(7):
613 - 618.
[Full Text]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|